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  A B S T R A C T  
  O b j e c t i v e s       T  o derive and validate a clinical score to risk 
stratify children presenting with acute infection.   
    Study design and participants    Observational  cohort 
study of children presenting with suspected infection 
to an emergency department in England. Detailed data 
were collected prospectively on presenting clinical 
features, laboratory investigations and outcome. Clinical 
predictors of serious bacterial infection (SBI) were 
explored in multivariate logistic regression models using 
part of the dataset, each model was then validated in 
an independent part of the dataset, and the best model 
was chosen for derivation of a clinical risk score for SBI. 
The ability of this score to risk stratify children with SBI 
was then assessed in the entire dataset.   
  Main  outcome  measure      Final diagnosis of SBI 
according to criteria deﬁ  ned by the Royal College 
of Paediatrics and Child Health working group on 
Recognising Acute Illness in Children.   
  R e s u l t s       Data from 1951 children were analysed. 74 
(3.8%) had SBI. The sensitivity of individual clinical signs 
was poor, although some were highly speciﬁ  c for SBI. A 
score was derived with reasonable ability to discriminate 
SBI (area under the receiver operator characteristics 
curve 0.77, 95% CI 0.71 to 0.83) and risk stratify children 
with suspected SBI.   
  C o n c l u s i o n s       This study demonstrates the potential 
utility of a clinical score in risk stratifying children with 
suspected SBI. Further work should aim to validate 
the score and its impact on clinical decision making 
in different settings, and ideally incorporate it into a 
broader management algorithm including additional 
investigations to further stratify a child’s risk.           
  I N T R O D U C T I O N  
  Serious bacterial infections (SBIs) are a leading 
cause of morbidity and mortality among children 
worldwide. A recent review of child deaths in 
England, Wales and Northern Ireland conﬁ  rmed 
that the largest single cause of death in children 
dying of an acute physical illness was infection, 
and found evidence that healthcare professionals 
in both hospital and primary care had difﬁ  culty 
identifying serious illness in children.    1    In another 
study of over 400 children with meningococcal 
sepsis in the UK, only half were referred to hospi-
tal at their ﬁ  rst primary care consultation, usually 
after a delay of several hours following the ﬁ  rst 
symptoms and/or signs of sepsis.    2    Early recogni-
tion of SBIs is associated with better treatment 
outcomes    3        4    but is challenging as many of the 
early clinical features also occur in self-limiting 
illnesses. In developed countries, discriminat-
ing serious infection from self-limiting illness 
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i  s further complicated by the low prevalence of 
serious infection in children presenting to hos-
pital emergency departments as well as primary 
care settings.    5    Better clinical tools are therefore 
required to improve the recognition of children 
with serious acute illness, particularly SBIs.    1        6        7    
  Clinical prediction rules utilising key clini-
cal features to generate a diagnostic or prognos-
tic score are increasingly used to risk stratify 
patients in a wide variety of clinical situations, 
particularly those in which diagnostic decisions 
are complicated, and in some areas have had a 
major impact on clinical service delivery.    8    –    15    We 
aimed to develop a simple clinical score with the 
ability to risk stratify children with possible SBIs 
presenting to a paediatric emergency department.   
  M E T H O D S  
  Patients  and  setting 
  As part of a large prospective study of patient care 
pathways, detailed clinical data were collected 
prospectively on all children presenting to the 
Queen’s Medical Centre Emergency Department 
in Nottingham between September 2000 and 
March 2001, and September 2001 and March 2002, 
  What i      s already known on this topic 
          Serious bacterial infections (SBI) are a leading    ▶
cause of childhood illness and death in the UK 
and worldwide. 
    In  clinical  practice,  discriminating  children    ▶
with SBI from those with other self-limiting 
infections is challenging. 
        A simple, validated clinical tool to risk stratify    ▶
and guide further management of children with 
suspected SBI would greatly improve their 
care.   
 What  t   his  study  adds 
          The high speciﬁ  city for SBI of some clinical    ▶
signs supports their use in clinical guidelines to 
identify seriously ill children. 
        The utility of a simple clinical score to stratify    ▶
children according to SBI risk is clearly 
demonstrated. 
        Combining this clinical tool with laboratory    ▶
tests in a broader management algorithm may 
further improve SBI diagnosis pathways.     
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with the exception of neonates and children requiring imme-
diate emergency resuscitation at presentation. A triage nurse 
recorded vital signs prior to assessment by emergency depart-
ment clinical staff. All clinical data including investigations, 
management and ﬁ  nal diagnoses were directly entered onto a 
standard proforma. Completed proformas were then scanned 
us ing  Fo rmi c  el e ctro ni c  da ta  ca pture  so ftw are  to  minimise  
data entry errors. Study clinicians checked the data for com-
pleteness, resolved data gaps and inconsistencies by re-review 
of the clinical notes, and recorded additional clinical data on 
children who were admitted. Children who re-attended hos-
pital within 1 week of discharge from either the emergency 
department or the ward were identiﬁ  ed from the electronic 
patient register, their notes reviewed, and ﬁ  nal diagnoses and 
SBI classiﬁ  cation amended in the light of their second pre-
sentation. A consultant paediatrician re-reviewed the patient 
records of all those admitted to check the accuracy of the data, 
particularly in relation to the ﬁ  nal diagnosis recorded. 
  Children were eligible for inclusion in this analysis if their 
differential diagnosis at presentation included acute infection. 
We excluded from the analysis children for whom data were 
insufﬁ  cient to conﬁ  dently assign outcome, or who had missing 
dates of birth.   
  Clinical  deﬁ  nitions 
  Automated measurements were used for temperature (tym-
panic thermometer), pulse rate, blood pressure and pulse oxim-
etry. Tachypnoea, tachycardia and hypotension were deﬁ  ned 
according to UK Advanced Paediatric Life Support guidelines    16   ; 
children for whom no blood pressure recordings were available 
were assumed not to be hypotensive for the purpose of the 
analysis. We adopted pragmatic deﬁ  nitions of mild hypoxia 
(SaO  2  <95% and/or documented oxygen therapy) and severe 
hypoxia (SaO  2  <90% and/or SaO  2  <92% despite documented 
oxygen therapy), and deﬁ  ned a ‘risk factor for infection’ as 
a documented history of any condition known to increase a 
child’s risk of invasive bacterial infection. Developmental 
delay was included separately as a potential risk factor, since 
several studies have documented an increased rate and sever-
ity of acute illness including infection among this group.    17        18    
Other deﬁ  nitions  reﬂ   ected those commonly used in clini-
cal practice (  table 1  ); data collected routinely on all children 
included level of consciousness, capillary reﬁ  ll time, hydration 
status, and presence and type of rash.   
  SBI was deﬁ  ned a priori as admission to hospital plus any of 
the following (in the absence of an alternative non-infective or 
non-bacterial diagnosis to explain the clinical and laboratory 
ﬁ  ndings): positive bacterial cultures from blood or another nor-
mally sterile site in the appropriate clinical context, radiologi-
cal signs of pneumonia, clinical meningitis plus a cerebrospinal 
ﬂ  uid polymorphonuclear leukocytosis, acute febrile purpura, 
deep collection(s) requiring intravenous antibiotics±surgical 
drainage, a white blood cell count ≥20×10  9  /l, a C reactive pro-
tein ≥120 mg/l, or a ﬁ  nal diagnosis of septic arthritis, osteomy-
elitis, empyema or mastoiditis.   
  Statistical  methods 
  Analyses were performed using Stata v 10 (StataCorp LP). The 
distribution of each variable was summarised with respect to 
SBI, and crude OR derived. The sensitivity, speciﬁ  city, positive 
and negative predictive values (PPV, NPV) and positive and 
negative likelihood ratios (LR+, LR−) were reported for each 
variable. 
  W e  rand o mly  assi gne d  ea ch  chil d  to  e i th e r  a  ‘ de ri v a ti o n ’  
o r  a  ‘ v ali d a ti o n ’  d a ta s e t ,  s u c h  th a t  ~ 85 %  o f  c hil d r e n  w e r e  
in the derivation set. Multivariate logistic regression models 
were then derived using the derivation set to develop a clini-
cal prediction score for SBI. We included in the model only 
variables with at least a weak association with SBI in the uni-
variate analysis (likelihood ratio test (LRT)   p value ≤0.1), ﬁ  rst 
conﬁ  ning this to categorical variables (which are more easily 
applied in clinical practice), and then repeating the analysis 
using the available continuous data to explore to what extent 
this improved the model. 
  Backwards stepwise logistic regression was performed ﬁ  rst 
using ‘standard’ selection criteria, such that variables not sig-
niﬁ  cantly associated with SBI (Wald p value <0.5; t test p value 
≤0.1 for continuous variables) are sequentially dropped from 
the model, and then using ‘sign OK’ selection,    19    whereby vari-
ables are eliminated from the model only if the sign (+ or −) 
of the regression coefﬁ  cient (β) is discordant with known or 
expected clinical associations (since standard selection criteria 
may not be optimal in the analysis of smaller datasets    15        19   –    21   ). 
  Each model took the form: SBI=α+β  1  X  1  +β  2  X  2  +β  3  X  3  +... 
+β  i  X  i  , where α is a constant, β  i   are the regression coefﬁ  cients 
for each variable (X  i  ) in the model, and X  i   are coded as 0 or 
1 (for binary variables), integers (for ordered categorical vari-
ables) or continuous numbers (for continuous variables). For 
each model we generated a score for each child, such that the 
score=β  1  X  1  +β  2  X  2  +β  3  X  3  +... +β  i  X  i  . The ability of each score to 
discriminate children with SBI was quantiﬁ  ed in the deriva-
tion dataset, and validated in the validation dataset, by cal-
culating the area under the receiver operator characteristics 
(ROC) curve (AUC) of score as a predictor of SBI. 
  Finally, the best model was selected to derive a simpler score 
for clinical use. Criteria for model selection included both 
discriminant ability (deﬁ  ned by the AUC) and model simplic-
ity. We generated a simpliﬁ  ed clinical prediction score using 
weightings deﬁ  ned by the β coefﬁ  cients of the chosen model, 
multiplied if necessary by a constant, and rounded as far as 
possible to the nearest integer. The discriminant ability of this 
ﬁ  nal ‘SBI score’ was tested by plotting an ROC curve of the 
score as a predictor of SBI in the entire dataset (derivation and 
validation sets combined). Risks of SBI were presented strati-
ﬁ  ed by score.   
  Ethics  approval 
  Ethics approval was granted by the Nottingham Research 
Ethics Committee and the ethics committee of the London 
School of Hygiene and Tropical Medicine.     
  R E S U L T S  
  There were 2341 eligible children, of whom 17 were excluded 
because insufﬁ  cient data were available to conﬁ  dently deter-
mine outcome. A further 373 children were excluded because 
their date of birth and therefore their age could not be posi-
tively determined from the hospital records due to uncertainty 
in interpreting their handwritten unique patient identiﬁ  er 
number on the proforma; the proportion of children with SBI 
did not differ signiﬁ  cantly between those for whom age data 
were and were not available (p=0.47). 
  The ﬁ  nal analysis therefore included 1951 children. Their 
median age was 19 months (range 1 month to 15 years) and 
55.4% were boys. Five hundred and forty-six (28.0%) chil-
dren were admitted at ﬁ  rst presentation, of whom 72 had 
SBI. Thirty-six children re-attended hospital within a week 
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of their initial presentation and within the same illness epi-
sode, 18 of whom were admitted and 2 of whom had SBI. The 
principal ﬁ  nal diagnoses of the 74 (3.8%) children with SBI 
included pneumonia (52), sepsis without a clear focus (14), 
soft tissue infections (5), urinary sepsis (2) and tonsillitis plus 
sepsis (1). 
  Several clinical variables were strongly associated with SBI 
in the univariate analysis (  table 1  ), including signs of a child’s 
a neurologic, haemodynamic and respiratory state, and a 
known risk factor for infection. Although hypotension was 
  Table  1         Univariable associations between clinical variables a  nd risk of serious bacterial infection (SBI) in children presenting to the emergency 
department  
 Clinical  variable   N*    SBI, n (%)   OR   95%  CI   p  Value 
Age group Infants (1–11 months) 701 26 (3.7) 1.35 0.31 to 5.81 0.784
Preschool (12–59 months) 855 31 (3.6) 1.32 0.31 to 5.62
School age (5–11 years) 323 15 (4.6) 1.70 0.38 to 7.65
Adolescents (12–15 years) 72 2 (2.8) 1.00 –
Sex Male 1081 39 (3.6) 1.00 – 0.562
Female 850 35 (4.1) 1.15 0.72 to 1.83
Risk factor for infection† No 1898 66 (3.5) 1.00 – <0.0001
Yes 53 8 (15.1) 4.93 2.23 to 10.9
Developmental delay No 1923 70 (3.6) 1.00 – 0.003
Yes 28 4 (14.3) 4.41 1.49 to 13.1
Consciousness level (AVPU score) Alert 1913 70 (3.7) 1.00 – 0.027
Responds to voice 18 0 (0.0) 0.00 –
Responds to pain 5 2 (40.0) 17.6 2.86 to 107.7
Unresponsive 1 0 (0.0) 0.00 –
State variation Awake 1909 68 (3.6) 1.00 – <0.0001
Eyes close brieﬂ  y 31 6 (19.4) 6.50 2.57 to 16.4
Falls asleep 1 0 (0.0) 0.00 –
Temperature‡ 35.0–36.4°C 426 9 (2.1) 0.82 0.37 to 1.82 <0.0001
36.5–37.5°C 780 20 (2.6) 1.00 –
37.5–38.4°C 205 17 (4.4) 1.86 1.01 to 3.43
≥38.5°C 305 28 (9.2) 4.10 2.39 to 7.05
Tachycardia Not tachycardic 974 22 (2.3) 1.00 – 0.0001
Tachycardic 651 39 (6.0) 2.76 1.61 to 4.71
Capillary reﬁ  ll time <2 s 1755 65 (3.7) 1.00 – <0.0001
≥2 s 40 7 (17.5) 5.52 2.34 to 13.0
Hydration status Well hydrated 1834 58 (3.2) 1.00 – <0.0001
Dry mucous membranes 102 12 (11.8) 4.08 2.11 to 7.90
Reduced skin turgor 9 4 (44.4) 24.5 6.30 to 95.3
Hypotension§ Not hypotensive 1947 74 (3.8) 1.00 – 0.691
Hypotensive 4 0 (0.0) 0.00 –
Tachypnoea Not tachypnoeic 656 19 (2.9) 1.00 – 0.028
Tachypnoeic 932 48 (5.2) 1.82 1.06 to 3.13
Hypoxia Not hypoxic 1620 49 (3.0) 1.00 – <0.0001
Mild hypoxia 265 16 (6.0) 2.06 1.15 to 3.68
Severe hypoxia 66 9 (13.6) 5.06 2.36 to 10.9
Purpuric rash None 1666 66 (4.0) 1.00 – 0.641
Purpuric rash 16 1 (6.3) 1.62 0.21 to 12.4
Petechial rash None 1666 66 (4.0) 1.00 – 0.793
Petechial rash 42 2 (4.8) 1.21 0.29 to 5.13
Macular rash None 1757 70 (4.0) 1.00 – 0.184
Macular rash 194 4 (2.1) 0.51 0.18 to 1.41
      *N indicates the total number children in a particular category. Note that the sum of N across all categories of a particular variable is equal to the total number of children 
for which data were available for that variable. For most variables this is less than the   total   number of children (1032) included in the analysis due to missing data for that 
particular variable. 
  †Identiﬁ  ed risk factors for bacterial infection in this analysis included neutropaenia, sickle cell disease, primary ciliary dyskinesia, Down’s syndrome, glycogen storage 
disease 1b, Hunter’s syndrome, Hurler’s syndrome, cryptogenic cirrhosis, biliary atresia, vesico-ureteric reﬂ  ux, hydronephrosis, congenital pneumonia and a documented 
history of recurrent bacterial infections. 
  ‡Temperature categories 35.0–36.4°C and 36.5–37.5°C were combined in the multivariate analysis to allow temperature to be modelled as a linear variable. No children had 
a temperature <35.0°C in this study. 
  §Blood pressure recordings were only available for 94 children; the remaining children were classiﬁ  ed as not hypotensive for the purposes of the analysis.     
not signiﬁ  cantly associated with SBI, it is important to note 
that blood pressure data were only available for 103 (5.3%) 
children. 
  The predictive values of each variable are summarised in 
  table 2  . Apart from tachypnoea (sensitivity 71.6%), the sensi-
tivity of most clinical signs was poor. However, some clinical 
signs, such a  s those of reduced level of consciousness/alertness 
and impaired perfusion were highly speciﬁ  c, and demonstrated 
more clinically useful positive likelihood ratios. The low prior 
probability of SBI in this population explains the apparently 
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high negative predictive values of many variables, reﬂ  ected in 
the poor utility of most negative likelihood ratios.   
  After random weighted allocation of children to the deri-
vation and validation sets, the derivation set comprised 1600 
(85.2%) children without SBI and 64 (86.5%) children with 
S B I .  Th e  m o d e l s  wi th  th e  b e s t  d i s c rimina ti v e  a b ili ty  w e r e  
those derived using ‘sign OK’ selection. For the ‘sign OK’ 
model conﬁ  ned to categorical variables, the AUCs in the der-
ivation and validation sets were 0.76 (0.68 to 0.82) a  nd 0.85 
(0.71 to 0.99), respectively. Inclusion of continuous data in the 
model did not markedly improve performance (AUC 0.76 and 
0.86 in the derivation and validation sets, respectively), so the 
simpler model conﬁ  ned to categorical variables was selected. 
Regression coefﬁ  cients and adjusted ORs and 95% CIs for each 
variable included in this model are given in   table 3  . A modiﬁ  ed 
SBI score was derived based on the β coefﬁ  cients of this model, 
such that:   
  Table  2         Predictive value of clinical variables for serious bacterial infection   
 Clinical  variable    Sensitivity, % (95% CI)    Speciﬁ  city, % (95% CI)    PPV, % (95% CI)    NPV, % (95% CI)    LR+ (95% CI)    LR− (95% CI) 
Risk factor for infection 10.8 (4.8 to 20.2) 97.6 (96.8 to 98.2) 15.1 (6.7 to 28.0) 96.5 (95.6 to 97.3) 4.5 (3.3 to 6.2) 0.91 (0.67 to 1.25)
Developmental delay 5.4 (1.5 to 13.3) 98.7 (98.1 to 99.2) 14.3 (4.0 to 32.7) 96.4 (95.4 to 97.2) 4.2 (4.2 to 4.3) 0.96 (0.95 to 0.97)
Consciousness level
  Not alert* 2.8 (0.34 to 9.7) 98.8 (98.2 to 99.3) 8.3 (1.0 to 27.0) 97.5 (96.7 to 98.1) 2.4 (1.7 to 3.3) 0.98 (0.7 to 1.4)
  No response to voice 2.8 (0.34 to 9.7) 99.8 (99.5 to 99.9) 33.3 (4.3 to 77.7) 96.4 (95.4 to 97.2) 13.0 (9.2 to 18.2) 0.97 (0.69 to 1.4)
  Unresponsive 0.0 (0.0 to 5.0)† 99.9 (99.7 to 100.0) 0.0 (0.0 to 97.5)† 96.1 (95.2 to 97.0) 0.0 1.0
State variation
  Eyes close brieﬂ  y or falls asleep 8.1 (3.0 to 16.8) 98.6 (98.0 to 99.1) 18.8 (7.2 to 36.4) 96.4 (95.5 to 97.2) 5.8 (7.0 to 4.9) 0.93 (0.78 to 1.1)
  Falls asleep 0.0 (0.0 to 4.9)† 99.9 (99.7 to 100.0) 0.0 (0.0 to 97.5)† 96.2 (95.2 to 97.0) 0.0 1.0
Temperature
  ≥37.5°C 60.8 (48.8 to 72.0) 64.5 (62.2 to 66.7) 6.5 (4.8 to 8.6) 2.4 (1.6 to 3.4) 1.7 (0.65 to 4.5) 0.61 (0.23 to 1.61)
  ≥38.5°C 37.8 (26.8 to 49.9) 84.8 (83.1 to 86.4) 9.2 (6.2 to 13.0) 97.1 (96.1 to 97.9) 2.5 (1.1 to 5.7) 0.73 (0.32 to 1.7)
Tachycardia 63.9 (50.6 to 75.8) 60.9 (58.4 to 63.3) 6.0 (4.3 to 8.1) 97.7 (96.6 to 98.6) 1.6 (0.67 to 4.0) 0.59 (0.24 to 1.5)
Capillary reﬁ  ll time ≥2 s 9.7 (4.0 to 19.0) 98.1 (97.3 to 98.7) 17.5 (7.3 to 32.8) 96.3 (95.3 to 97.1) 5.1 (4.0 to 6.5) 0.92 (0.72 to 1.2)
Hydration status
  Dry mucous membranes 21.6 (12.9 to 32.7) 94.9 (93.8 to 95.9) 14.4 (8.5 to 22.4) 96.8 (95.9 to 97.6) 4.3 (2.3 to 7.8) 0.83 (0.45 to 1.5)
  Reduced skin turgor 5.4 (1.5 to 13.3) 99.7 (99.4 to 99.9) 44.4 (13.7 to 78.8) 96.4 (95.4 to 97.2) 20.2 (20.1 to 20.4) 0.95 (0.94 to 0.96)
Hypotension 0.0 (0.0 to 4.9)† 99.8 (99.5 to 99.9) 0.0 (0.0 to 60.2)† 96.2 (95.3 to 97.0) 0.0 1.0
Tachypnoea 71.6 (59.3 to 82.0) 41.9 (39.4 to 44.4) 5.2 (3.8 to 6.8) 97.1 (95.5 to 98.2) 1.2 (0.47 to 3.2) 0.68 (0.26 to 1.8)
Hypoxia
  Mild or severe 33.8 (23.2 to 45.7) 83.7 (81.9 to 85.3) 7.6 (4.9 to 10.9) 97.0 (96.0 to 97.8) 2.1 (0.95 to 4.5) 0.79 (0.36 to 1.7)
  Severe 12.2 (5.7 to 21.8) 97.0 (96.1 to 97.7) 13.6 (6.4 to 24.3) 966 (95.6 to 97.3) 4.0 (2.8 to 5.8) 0.91 (0.63 to 1.3)
Rash
  Purpuric rash 1.5 (0.04 to 8.0) 99.1 (98.5 to 99.5) 6.3 (0.2 to 30.2) 96.0 (95.0 to 96.9) 1.6 (0.8 to 3.2) 0.99 (0.50 to 2.0)
  Petechial rash 2.9 (0.4 to 10.2) 97.6 (96.7 to 98.3) 4.8 (0.6 to 16.2) 96.0 (95.0 to 96.9) 1.1 (0.79 to 1.6) 1.0 (0.71 to 1.4)
 Macular  rash 5.4 (1.5 to 13.3) 89.9 (88.4 to 91.2) 2.1 (0.6 to 5.2) 96.0 (95.0 to 96.9) 0.53 (0.53 to 0.54) 1.1 (1.0 to 1.1)
      *Not alert indicates only responds to voice or pain, or unresponsive. 
  †One sided, 97.5% CI. 
  LR+, likelihood ratio of a positive test; LR−, likelihood ratio of a negative test; NPV, predictive value of a negative test; PPV, predictive value o  f a positive test.     
  Table  3      Regression  coefﬁ   cients  (β), and adjusted OR and 95% CI for 
variables included in the chosen model   
 Variables    β Coefﬁ  cient   OR   95%  CI   p  Value 
History of developmental delay 1.6807 5.4 1.6 to 18.6 0.008
Risk factor for infection 1.4408 4.2 0.9 to 20.9 0.077
State variation 0.2336 1.3 0.3 to 4.7 0.728
Temperature category 0.6643 1.9 1.4 to 2.7 <0.001
Capillary reﬁ  ll time 0.6595 1.9 0.6 to 5.8 0.243
Dehydration category 1.3651 39 2.0 to 7.6 <0.001
Tachypnoea 0.1760 1.2 0.6 to 2.2 0.585
Hypoxia category 0.4734 1.6 1.1 to 2.4 0.026
  The AUC for SBI score as a predictor of SBI in the derivation 
and validation sets combined was 0.77 (95% CI 0.71 to 0.83; 
  ﬁ  gure 1  ).   Table 4   shows t  he SBI score in tabular form more 
conveniently for clinical use, and risks of SBI stratiﬁ  ed by SB  I 
score are shown in   table 5  .         
  DISCUSSION 
  By exploring the feasibility of developing a clinical prediction 
score for risk stratiﬁ  cation of suspected serious bacterial ill-
ness in children, this study addresses an important challenge 
in everyday clinical practice in the UK and other developed 
countries.    1        2        5        7    Among children presenting to emergency care 
in whom infection was suspected (where the prior probability 
of SBI was 5%), our SBI score was able to rule out SBI with 
reasonable conﬁ  dence and precision in three quarters of chil-
dren in the dataset to whom the score was applied (SBI score 
≤5 associated with <2% risk of SBI), to identify children at the 
highest risk of SBI (a third of children with an SBI score >8 had 
SBI) and to risk stratify the remaining children into groups 
with increasing risk. 
  W e modelled continuous data as categorical and continu-
ous variables in separate models. Although less suitable for the 
development of a clinical prediction score for clinicians, con-
tinuous variables maximise information    15        22    and can be util-
ised in computer-assisted diagnostic pathways. However, their 
inclusion in the model did not improve discriminative ability 
sufﬁ  ciently to justify the increased complexity. 
  Previous studies in developed countries have attempted to 
derive clinical scores as a tool to identify seriously ill children 
at presentation.    23    –    35     Most were carried out in populations 
with a higher incidence of SBI prior to the introduction of 
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routine vaccination against   Haemophilus inﬂ  uenza   type b (Hib) 
and   Streptococcus pneumoniae  ; others were designed to predict 
the need for admission to intensive care.    9    Moreover, promis-
ing initial reports of diagnostic performance have not always 
been consistently reproducible.    27        36         37    This probably reﬂ  ects 
a combination of the inherent over-optimism of data-driven 
model predictions based on small datasets,    15        19        21        38    –    40     failure 
to validate models and/or scores in an independent dataset,    15        19    
and spectrum bias arising from the use of case–control 
designs.    41   –    43     In a recent study based mainly in primary care, a 
clinical algorithm was derived with the ability to rule out SBI 
with reasonable conﬁ  dence.    44     However, these results have not 
been validated in an independent dataset, and negative predic-
tive values are likely to be lower in emergency department set-
tings where the prior probability of SBI is higher. 
  The strengths of our study include the large number of chil-
dren studied, detailed review of all clinical and laboratory data 
to assign outcome, validation of the model in an independent 
part of the dataset, and inclusion of all children presenting with 
suspected SBI in a cohort study design, which suggests the pre-
dictive value of our SBI score should be generalisable to other 
similar settings. Furthermore, focusing on children with sus-
pected SBI rather than all children with serious illness allowed 
inclusion of clinical risk factors speciﬁ  c to infection, and may 
have helped improve model speciﬁ  city. It is important to stress 
that while the SBI score should be generalisable to emergency 
departments in the developed world, it is unlikely to be appli-
cable to developing world settings where the prevalence of SBI 
among paediatric presentations is much higher and there may 
be other important risk factors for infection such as malnutri-
tion and HIV.    5    
  A potential limitation of the study concerns the deﬁ  nition 
of SBI. No single, reliable gold standard exists for the diagnosis 
of invasive bacterial infections in children. Although cultures 
from blood and other sterile sites are highly speciﬁ  c, sensitiv-
ity is limited.    45    –    47    The deﬁ  nition of SBI used has been formu-
lated to take account of all available clinical and laboratory 
information in deﬁ  ning each clinical syndrome, including a 
child’s response to treatment, and is designed to capture all 
children with invasive or otherwise SBIs who require admis-
sion to hospital. A potential criticism is the risk of incorpo-
ration bias, since clinicians are not blind to the admission 
  Figure  1         Receiver operator characteristics (ROC) curve of serious 
bacterial infection score as a predictor of serious bacterial infection in 
the  entire  dataset.    
  Table  4         Serious bacterial infection (SBI) score f  or prediction of 
serious bacterial infection   
 Clinical  variable     Score* 
Developmental delay No delay 0
Delay 4
Risk factor for infection No risk factor 0
Risk factor present 2
State variation Eyes open 0
Eyes close brieﬂ  y 1
Falls asleep 2
Temperature <37.5°C 0
37.5–38.4°C 1
≥38.5°C 2
Capillary reﬁ  ll time (s) <2 0
≥21
Hydration status Well hydrated 0
Dry mucous membranes 2
Reduced skin turgor 4
Respiratory rate Not tachypnoeic 0
Tachypnoeic 1
Hypoxia Not hypoxic 0
Mild hypoxia 1
Severe hypoxia 2
      *Score indicates the sum of scores for each clinical variable (maximum score 18). 
  Table 5   sho  ws risks of serious bacterial infection stratiﬁ  ed by SBI score.     
clinical variables studied, which are likely to inﬂ  uence admis-
sion decisions; inclusion of clinical and laboratory data from 
the entire admission in assigning outcome is likely to only 
partly mitigate this bias. Nevertheless, we believe the deﬁ  -
nition adopted represents a pragmatic working deﬁ  nition of 
SBI. Importantly, we were also able to identify those children 
discharged from hospital who re-attended within a week, 
and to amend their SBI classiﬁ  cation as required. While we 
cannot exclude the possibility that other children may have 
re-presented elsewhere, the nearest emergency department, 
which does not have a dedicated paediatric section, is 18 miles 
away, so the chance of this is small. Similarly, since sudden 
childhood death is rare in this population and most cases are 
brought to hospital, the chance of a child in this study dying at 
home and not re-attending hospital is also small. 
  Missing data also limit the power of our analysis. Although 
the proportion of data missing for individual variables was 
generally small, this became more signiﬁ  cant in the multivari-
ate analysis. Blood pressure is not routinely measured in pae-
diatric clinical practice except in the sickest children, so data 
were missing for most patients. Nevertheless, blood pressure 
may have an important role in predicting SBI that this analy-
sis would not be able to identify. The number of children for 
whom age data were missing is unfortunate as it further limits 
study power; however, this is unlikely to have introduced any 
bias since the underlying problem (poor legibility of the pro-
forma) is unlikely to be related to the clinical presentation and 
was not associated with SBI. 
  Finally, measurement error is also possible, since emergency 
department staff assessed each clinical sign using routine clin-
ical tools. For some variables this is likely to be minimal since 
automated measurements were used. Arguably, even for other 
variables this may be seen as a strength of the study, since it 
increases its generalisability to the routine clinical setting. 
  The implications of this study for clinical practice are three-
fold. First, the speciﬁ  city of some clinical signs for SBI (such 
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as reduced activity or level of consciousness, prolonged capil-
lary reﬁ  ll time and reduced skin turgor) support the National 
Institute for Health and Clinical Excellence clinical guidelines    7    
which use these clinical features as ‘red ﬂ  ags’ to identify seri-
ously ill children. The presence of these features in a febrile 
child should prompt a careful clinical assessment. Second, it 
clearly demonstrates the potential utility of a clinical score to 
stratify children according to their risk of SBI. Such a score 
might be incorporated into electronic decision support and 
medical records. Finally, it underlines the need to use such 
a clinical score as part of a broader algorithm to guide man-
agement decisions (including additional investigations, plans 
for review or admission for observation) to further stratify 
a child’s risk. Future research should explore the beneﬁ  t of 
including in the model other risk factors such as immunisation 
status, routine blood pressure measurement, and other poten-
tial markers of sepsis such as limb pain or cool peripheries,    2    
investigate how laboratory tests such as C-reactive protein, 
procalcitonin and white blood cell count may best be incorpo-
rated into a clinical algorithm to reﬁ  ne a child’s risk status, and 
further validate the performance and impact    14        48     of the score 
in different acute paediatric settings, including primary care.      
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